VALEANT INTERNAT BARBADOS SRL has a total of 14 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), Israel and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are BIOVAIL LAB INT SRL, ADVENTRX PHARMACEUTICALS INC and AKRON MOLECULES GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Israel | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Canada | 1 | |
#5 | Hong Kong | 1 | |
#6 | Malaysia | 1 | |
#7 | New Zealand | 1 | |
#8 | Singapore | 1 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Jackson Graham | 4 |
#2 | Williams Robert Parry | 3 |
#3 | Silverstone Peter Harris | 3 |
#4 | Lai John Ck | 2 |
#5 | Saleh Mohammad Ashty | 2 |
#6 | Turchetta Stefano | 2 |
#7 | Frisbee Steven E | 2 |
#8 | Lim Johnson | 2 |
#9 | Zhou Fang | 2 |
#10 | Oberegger Werner | 2 |
Publication | Filing date | Title |
---|---|---|
WO2012112636A1 | Cylindrical ocular inserts | |
WO2012112638A1 | Ocular strips | |
CA2771539A1 | Pharmaceutical compositions with tetrabenzine | |
MY145995A | Modified-release tablet of bupropion hydrochloride |